Associated Papers
Discovery of a Novel Missense Variant in NLRP3 Causing Atypical Cryopyrin-Associated Periodic Syndromes With Hearing Loss as the Primary Presentation, Responsive to Anti-Interleukin-1 Therapy.
Birk-Bachar M et al.
Arthritis & Rheumatology (hoboken, N.j.), 2024
Hearing Loss as the Main Clinical Presentation in NLRP3-Associated Autoinflammatory Disease.
Oziębło D et al.
Frontiers in Immunology, 2022
Select a paper to view details